PROCTER & GAMBLE HEALTH | MERCURY LAB. | PROCTER & GAMBLE HEALTH/ MERCURY LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 26.1 | 132.6% | View Chart |
P/BV | x | 10.6 | 2.4 | 448.9% | View Chart |
Dividend Yield | % | 2.0 | 0.4 | 513.6% |
PROCTER & GAMBLE HEALTH MERCURY LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
MERCURY LAB. Mar-23 |
PROCTER & GAMBLE HEALTH/ MERCURY LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,000 | 536.6% | |
Low | Rs | 3,883 | 390 | 995.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 627.8 | 118.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 46.5 | 297.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 67.2 | 231.0% | |
Dividends per share (Unadj.) | Rs | 95.00 | 3.50 | 2,714.3% | |
Avg Dividend yield | % | 2.1 | 0.5 | 407.9% | |
Book value per share (Unadj.) | Rs | 447.6 | 380.2 | 117.7% | |
Shares outstanding (eoy) | m | 16.60 | 1.20 | 1,383.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.1 | 563.9% | |
Avg P/E ratio | x | 33.5 | 14.9 | 223.8% | |
P/CF ratio (eoy) | x | 29.8 | 10.3 | 288.1% | |
Price / Book Value ratio | x | 10.3 | 1.8 | 565.2% | |
Dividend payout | % | 68.7 | 7.5 | 912.8% | |
Avg Mkt Cap | Rs m | 76,761 | 834 | 9,203.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 139 | 1,482.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 753 | 1,632.2% | |
Other income | Rs m | 184 | 17 | 1,069.8% | |
Total revenues | Rs m | 12,480 | 771 | 1,619.7% | |
Gross profit | Rs m | 3,247 | 86 | 3,767.0% | |
Depreciation | Rs m | 281 | 25 | 1,131.7% | |
Interest | Rs m | 8 | 4 | 212.7% | |
Profit before tax | Rs m | 3,142 | 75 | 4,193.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 19 | 4,426.9% | |
Profit after tax | Rs m | 2,295 | 56 | 4,113.1% | |
Gross profit margin | % | 26.4 | 11.4 | 230.8% | |
Effective tax rate | % | 27.0 | 25.5 | 105.6% | |
Net profit margin | % | 18.7 | 7.4 | 252.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 417 | 2,808.2% | |
Current liabilities | Rs m | 6,791 | 164 | 4,133.7% | |
Net working cap to sales | % | 40.0 | 33.6 | 119.3% | |
Current ratio | x | 1.7 | 2.5 | 67.9% | |
Inventory Days | Days | 263 | 7 | 3,679.4% | |
Debtors Days | Days | 343 | 1,035 | 33.2% | |
Net fixed assets | Rs m | 10,617 | 259 | 4,104.4% | |
Share capital | Rs m | 166 | 12 | 1,383.3% | |
"Free" reserves | Rs m | 7,265 | 444 | 1,635.1% | |
Net worth | Rs m | 7,431 | 456 | 1,628.5% | |
Long term debt | Rs m | 0 | 24 | 0.0% | |
Total assets | Rs m | 22,330 | 676 | 3,304.4% | |
Interest coverage | x | 409.1 | 21.7 | 1,885.1% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.1 | 49.4% | |
Return on assets | % | 10.3 | 8.8 | 117.3% | |
Return on equity | % | 30.9 | 12.2 | 252.6% | |
Return on capital | % | 42.4 | 16.3 | 259.3% | |
Exports to sales | % | 0 | 25.3 | 0.0% | |
Imports to sales | % | 13.1 | 0.4 | 3,711.6% | |
Exports (fob) | Rs m | NA | 191 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 3 | 60,581.1% | |
Fx inflow | Rs m | 1,465 | 191 | 768.0% | |
Fx outflow | Rs m | 1,605 | 8 | 20,321.5% | |
Net fx | Rs m | -140 | 183 | -76.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 25 | 9,624.8% | |
From Investments | Rs m | -215 | -11 | 2,034.1% | |
From Financial Activity | Rs m | -985 | -10 | 9,720.6% | |
Net Cashflow | Rs m | 1,160 | 4 | 30,295.0% |
Indian Promoters | % | 0.0 | 73.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 26.3 | 182.9% | |
Shareholders | 56,778 | 1,214 | 4,676.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | MERCURY LAB. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 4.18% | 0.45% |
1-Month | -1.15% | 8.15% | 2.55% |
1-Year | 0.73% | 48.64% | 56.14% |
3-Year CAGR | -8.76% | 6.89% | 15.22% |
5-Year CAGR | 4.97% | 25.25% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the MERCURY LAB. share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of MERCURY LAB..
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.5%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of MERCURY LAB..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.